TrialEuropean radiology2023

Low dose of contrast agent and low radiation liver computed tomography with deep-learning-based contrast boosting model in participants at high-risk for hepatocellular carcinoma: prospective, randomized, double-blind study.

Hyo-Jin Kang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.